A multi-institutional research team has found a way to target the p.53 gene with drugs, the absence of which is responsible for the further growth of mutant cancers such as breast, ovarian and lung cancer.
Researchers are able to do this by identifying a group of enzymes responsible for aberrations in the gene and targeting it with agents to prevent further growth of the cancer. Their findings are published in the journal Cell.